“There are only a few centres at the moment who could really give this drug effectively," says Professor Sir John Hardy (×î×¼µÄÁùºÏ²ÊÂÛ̳ Queen Square Institute of Neurology) about two new Alzheimer's drugs donanemab and lecanemab, adding that dementia care in the UK needs "a rethink."
, ,Ìý